Tags

Type your tag names separated by a space and hit enter

Coenzyme Q10 and cardiovascular disease: a review.
J Cardiovasc Nurs 2002; 16(4):9-20JC

Abstract

This article provides a comprehensive review of 30 years of research on the use of coenzyme Q10 in prevention and treatment of cardiovascular disease. This endogenous antioxidant has potential for use in prevention and treatment of cardiovascular disease, particularly hypertension, hyperlipidemia, coronary artery disease, and heart failure. It appears that levels of coenzyme Q10 are decreased during therapy with HMG-CoA reductase inhibitors, gemfibrozil, Adriamycin, and certain beta blockers. Further clinical trials are warranted, but because of its low toxicity it may be appropriate to recommend coenzyme Q10 to select patients as an adjunct to conventional treatment.

Authors+Show Affiliations

Department of Nursing, University of Southern California, Los Angeles, California, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

12597259

Citation

Sarter, Barbara. "Coenzyme Q10 and Cardiovascular Disease: a Review." The Journal of Cardiovascular Nursing, vol. 16, no. 4, 2002, pp. 9-20.
Sarter B. Coenzyme Q10 and cardiovascular disease: a review. J Cardiovasc Nurs. 2002;16(4):9-20.
Sarter, B. (2002). Coenzyme Q10 and cardiovascular disease: a review. The Journal of Cardiovascular Nursing, 16(4), pp. 9-20.
Sarter B. Coenzyme Q10 and Cardiovascular Disease: a Review. J Cardiovasc Nurs. 2002;16(4):9-20. PubMed PMID: 12597259.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Coenzyme Q10 and cardiovascular disease: a review. A1 - Sarter,Barbara, PY - 2003/2/25/pubmed PY - 2003/3/19/medline PY - 2003/2/25/entrez SP - 9 EP - 20 JF - The Journal of cardiovascular nursing JO - J Cardiovasc Nurs VL - 16 IS - 4 N2 - This article provides a comprehensive review of 30 years of research on the use of coenzyme Q10 in prevention and treatment of cardiovascular disease. This endogenous antioxidant has potential for use in prevention and treatment of cardiovascular disease, particularly hypertension, hyperlipidemia, coronary artery disease, and heart failure. It appears that levels of coenzyme Q10 are decreased during therapy with HMG-CoA reductase inhibitors, gemfibrozil, Adriamycin, and certain beta blockers. Further clinical trials are warranted, but because of its low toxicity it may be appropriate to recommend coenzyme Q10 to select patients as an adjunct to conventional treatment. SN - 0889-4655 UR - https://www.unboundmedicine.com/medline/citation/12597259/Coenzyme_Q10_and_cardiovascular_disease:_a_review_ L2 - http://Insights.ovid.com/pubmed?pmid=12597259 DB - PRIME DP - Unbound Medicine ER -